Dandan Lin

This study identifies a mutation that suppresses SAVI phenotypes in MITA/STING gain-of-function mutants and proposes a therapeutic strategy using a peptide inhibitor.

This study shows that GPX4 loss in tumor cells promotes NSCLC by reprogramming lipid metabolism and suppressing antitumor immunity through ferroptosis evasion and immunoinhibitory TME.